IFITM3 作为一个 PIP3 支架来放大 B 细胞中的 PI3K 信号
Jaewoong Lee1, Mark E Robinson1, Ning Ma2
1Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Nature
|November 5, 2020
概括
干扰素诱导的跨膜蛋白3 (IFITM3) 是B细胞癌症的一个关键因素. IFITM3的酸化驱动PI3K信号,这对癌细胞生长和存活至关重要.
科学领域:
- 免疫学
- 分子生物学
- 癌症学
背景情况:
- 通过阻断病毒进入内分体,因其抗病毒性质而闻名.
- 然而,它在B细胞恶性瘤中的作用在很大程度上仍未被探索.
研究的目的:
- 研究IFITM3在B细胞白血病和淋巴瘤中的作用.
- 阐明IFITM3影响B细胞信号和转换的分子机制.
主要方法:
- 对B细胞白血病和淋巴瘤的临床患者队列的分析.
- 对IFITM3 (Tyr20) 的酸化位点分析.
- 鼠标模型 (Ifitm3-/-) 和体外细胞转化试验.
- 生物化学测试以确定IFITM3在PIP3和PI3K信号传递中的支架功能.
主要成果:
- 在B细胞癌症中,IFITM3表达和Tyr20酸化预测出不佳的结果.
- 诱导IFITM3酸化和细胞表面定位.
- 如果itm3缺乏,会影响B细胞的发育,生殖中心的形成和抗体的产生.
- IFITM3充当PIP3支架,增强B细胞转化和癌基因驱动的恶性瘤所必需的PI3K信号.
- IFITM3的损失会破坏脂质PIP3水平,损害BCR信号传递和细胞粘附.
结论:
- 在Tyr20中IFITM3的酸化是一个关键的开关,它将其功能从抗病毒防御重定向到B细胞中的PI3K信号放大.
- 通过IFITM3介导的PI3K信号放大对高亲和B细胞扩张和恶性转变至关重要.
- 在B细胞白血病和淋巴瘤中,IFITM3是潜在的治疗点.
更多相关视频
11:44A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
12.3K
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
8.8K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.9K
Phosphoinositides and PIPs
9.8K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.8K
IP3/DAG Signaling Pathway
13.6K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.6K
The JAK-STAT Signaling Pathway
10.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.7K
Intracellular Signaling Affects Focal Adhesions
3.3K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.3K
mTOR Signaling and Cancer Progression
4.3K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.3K
